Ci Therapeutics brings together the patented CannTrap technology by CannRx which combusts, captures and stabilizers raw materials producing “liquid cannabis smoke”.
This technology is combined with an FDA approved, hand-held Nebulizer. This platform will deliver multiple formulations starting with sleep and anxiety. The initial device is focused on the over 65+ and institutional medical cannabis users in the 28 Medical programs in the United States. In addition we are developing a next generation device that will expand the market profile.